Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Explore private companies / VeraDermics IPO
VeraDermics

VeraDermics IPO

$306.13MM
Series C Valuation, Oct 2025
Completed IPO
Learn More About VeraDermics Stock
Register for details
For more details on financing and valuation of private companies similar to VeraDermics before its IPO, register or log in today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

VeraDermics IPO date and status

2019
Founded
Jan 2026
S-1 Filed
www.sec.gov
Feb 2026
IPO Completed
www.bloomberg.com

Company details

Veradermics is a medical dermatology company which offers first-in-class therapeutics designed to address prevalent skin conditions to patients. Their pipeline includes potential treatments for androgenetic alopecia, common warts, alopecia areata, molluscum contagiosum, and atopic dermatitis. Veradermics leverages clinical expertise striving to develop novel drugs that aim to solve pervasive treatment challenges in dermatology practice. This company was founded by Reid Waldman MD and Ming Lee MD in 2019 and is headquartered in New Haven, CT.
veradermics.com
Sector
Healthcare
Subsector
Healthcare Software
Founded
2019
Headquarters
New Haven, CT, United States
Forge Price 1
Price not available
Market Activity 2
Limited
Last Matched Price
Get Full Access
Post-Money Valuation 3
$306.13MM
Total Funding
$263.24MM
Last Funding Round
Series C

Learn more about VeraDermics

To invest in VeraDermics pre-IPO

Can you invest in VeraDermics pre-IPO?

You may invest in VeraDermics as it is a public company listed on the NYSE with ticker MANE. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of VeraDermics before it goes public?

You can no longer sell shares of VeraDermics on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my VeraDermics shares?

Forge can no longer determine the value of VeraDermics shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is VeraDermics a publicly traded company?

VeraDermics became a public company following its IPO on 02/04/2026 and is now traded on the NYSE under the ticker MANE.

To learn more about VeraDermics potential IPO

Will VeraDermics go IPO?

VeraDermics became a public company following its IPO on 02/04/2026 and is now traded on the NYSE under the ticker MANE.

What is VeraDermics’ IPO price?

The IPO price of VeraDermics is not currently available.

When was VeraDermics founded?

VeraDermics was founded in 2019.

What is VeraDermics funding to date?

VeraDermics has raised $263.24MM to date.

VeraDermics major investors

Chemwerth Therapeutics
Connecticut Innovations
Longitude Capital
MassMEDIC
North Point Capital
Osage University Partners
PhiFund Ventures
Prospect Hill Growth Partners
Surveyor Capital
Suvretta Capital Management
Werth Ventures
Show All InvestorsShow Fewer Investors

VeraDermics pre-IPO valuation and funding rounds

Funding history chart
Funding round and deals details
Funding Date Round Amount Raised Price per Share Post-Money Valuation 3 Key Investors
10/16/2025 Series C $151MM $1.27 $306.13MM Abrdn, Columbia Threadneedle Investments, Infinitium, Invus, Lifesci Venture Partners, Longitude Capital, Marshall Wace, Sr One, Surveyor Capital, Suvretta Capital Management, Viking Global Investors
Price per Share
$ xx.xx
Shares Outstanding
118,682,683
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
12.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Abrdn, Columbia Threadneedle Investments, Infinitium, Invus, Lifesci Venture Partners, Longitude Capital, Marshall Wace, Sr One, Surveyor Capital, Suvretta Capital Management, Viking Global Investors
12/11/2024 Series B $75MM $1.20 $129.29MM Connecticut Innovations, Longitude Capital, Osage University Partners, PhiFund, Prospect Hill Growth Partners, Surveyor Capital, Suvretta Capital Management, Vladimir Coric Family Trust
Price per Share
$ xx.xx
Shares Outstanding
62,245,805
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
12.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Connecticut Innovations, Longitude Capital, Osage University Partners, PhiFund, Prospect Hill Growth Partners, Surveyor Capital, Suvretta Capital Management, Vladimir Coric Family Trust
04/25/2023 Series A-4 $15MM $3.02 $64.77MM Undisclosed Investors
Price per Share
$ xx.xx
Shares Outstanding
4,965,572
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
09/22/2021 Series A-3 $2.02MM $2.88 $45.46MM Connecticut Innovations, Prospect Hill Growth Partners, Vladimir Coric Family Trust
Price per Share
$ xx.xx
Shares Outstanding
703,475
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Connecticut Innovations, Prospect Hill Growth Partners, Vladimir Coric Family Trust
09/22/2021 Series A-1 $18.75MM $2.88 $45.46MM Connecticut Innovations, Prospect Hill Growth Partners, Vladimir Coric Family Trust
Price per Share
$ xx.xx
Shares Outstanding
6,515,849
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Connecticut Innovations, Prospect Hill Growth Partners, Vladimir Coric Family Trust
09/22/2021 Series A-2 $1.47MM $2.16 $45.46MM Connecticut Innovations, Prospect Hill Growth Partners, Vladimir Coric Family Trust
Price per Share
$ xx.xx
Shares Outstanding
680,479
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Connecticut Innovations, Prospect Hill Growth Partners, Vladimir Coric Family Trust

VeraDermics IPO news and media highlights

Pulse 2.0 10/19/2025

Veradermics: $150 Million Series C Raised For Advancing Late-Stage Trials Of VDPHL01

Veradermics, a dermatologist-founded, late clinical-stage biopharmaceutical company developing first-in-class treatments for common dermatologic conditions, has announced the completion of an oversubscribed $150 million Series C financing round.
Business Wire 12/11/2024

Veradermics Raises $75 Million in Series B Financing and Initiates Phase 2/3 Trial for Hair Loss

Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions, announced today the closing of a $75 million Series B financing. The financing was led by Suvretta Capital Management and included new investors Longitude Capital, Surveyor Capital (a Citadel company), Osage University Partners, and PhiFund. Existing investors, JW Childs Associates, Connecticut Innovations, and Vlad Coric, MD, also participated in this round. In connection with this financing, Amanda Birdsey-Benson, PhD from Suvretta Capital Management and Patrick Enright from Longitude Capital will join the Veradermics Board of Directors.
Forbes 09/23/2021

This Startup Raised $20.7 Million To Develop A Kid-Friendly Wart Treatment

Around 1.5 million people are diagnosed for common warts, and one of the most common solutions involves using liquid nitrogen to “freeze” the wart, which can be painful and scary. VeraDermics, a Connecticut -based startup founded by dermatologists, is hoping to change that with the development of its kid-friendly wart treatment by using a patch. “Not a lot of drugs have been developed specifically for dermatology conditions affecting children. What we were looking for was something that had adoptability by kids — something familiar to them like a Band Aid,” says cofounder and COO Reid Waldman, 27.
Browse More Insights

Private companies exploring an IPO

See which private companies are preparing for the public market. Register to get full access to the latest secondary market pricing data.

Sector: Healthcare
Subsector: Healthcare Software
Trade Metrics Last Funding Round
Company Forge Price Last Matched Round Post-Money Valuation 3 Price Per Share Amount Raised
Spyglass PharmaSpyglass PharmaNot available$ xx.xxSeries D$350.04MM$2.33$75MM
Affinia TherapeuticsAffinia TherapeuticsNot available$ xx.xxSeries C$156.61MM$1.62$40MM
OriginOriginNot available$ xx.xxNot available------
See Tech IPO Calendar

Private market movers

Track trading activity and investor momentum across thousands of private companies. Register to view last matched prices and additional transactional details.

Actively traded

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
SpaceX SpaceX $550.00 +$102.77 (22.98%)High $xxx.xx
Anduril Anduril $114.78 +$9.78 (9.31%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx
See All Actively Traded Companies

Artificial Intelligence (AI)

Company Forge Price Market Activity Last Matched
Anthropic Anthropic $259.14 -$13.84 (5.07%)High $xxx.xx
OpenAI OpenAI $723.12 +$0.12 (0.02%)High $xxx.xx
Anduril Anduril $114.78 +$9.78 (9.31%)High $xxx.xx
Databricks Databricks $197.72 +$0.06 (0.03%)High $xxx.xx
Groq Groq $29.77 -$0.01 (0.03%)High $xxx.xx
See All AI Companies

Forge, your trusted partner for pre-IPO insights and VeraDermics data

Forge is the trusted platform for buying and selling pre-IPO shares. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Register

Updated on: Feb 6, 2026

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions on Forge.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Actively traded companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.